Markel Group Inc. Acquires 6,000 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Markel Group Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 120.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,000 shares of the healthcare conglomerate's stock after acquiring an additional 6,000 shares during the quarter. Markel Group Inc.'s holdings in UnitedHealth Group were worth $5,791,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Iron Horse Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate's stock valued at $614,000 after purchasing an additional 19 shares during the last quarter. Secure Asset Management LLC boosted its stake in shares of UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate's stock valued at $1,238,000 after purchasing an additional 19 shares during the last quarter. Bensler LLC boosted its stake in shares of UnitedHealth Group by 0.3% in the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate's stock valued at $3,677,000 after purchasing an additional 19 shares during the last quarter. Texas Capital Bancshares Inc TX boosted its stake in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate's stock valued at $855,000 after purchasing an additional 19 shares during the last quarter. Finally, Tealwood Asset Management Inc. boosted its stake in UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate's stock worth $2,626,000 after acquiring an additional 19 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH traded up $1.49 during trading hours on Friday, reaching $495.35. 2,608,554 shares of the company were exchanged, compared to its average volume of 4,508,195. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The business's 50 day simple moving average is $485.84 and its 200-day simple moving average is $514.21. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.41 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm's quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.26 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group's dividend payout ratio is presently 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company's stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Truist Financial reissued a "buy" rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a "buy" rating in a research note on Friday, April 19th. Erste Group Bank restated a "hold" rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an "overweight" rating in a report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.